Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2′-O-ribose methyltransferase-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2′-O-ribose methyltransferase

Published:2020-04-20 Issue:8 Volume:39 Page:2679-2692
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Khan Rameez Jabeer¹,Jha Rajat Kumar¹,Amera Gizachew Muluneh¹,Jain Monika¹,Singh Ekampreet¹,Pathak Amita²,Singh Rashmi Prabha³,Muthukumaran Jayaraman¹,Singh Amit Kumar¹

Affiliation:

1. Department of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, U.P, India

2. Department of Chemistry, Indian Institute of Technology, New Delhi, India

3. Department of Biotechnology, IILM College of Engineering & Technology, Greater Noida, U.P, India

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2020.1753577

Reference56 articles.

1. Abraham, M. J., Lindahl, D., van der Spoel, E., Hess, B. & the GROMACS development team. (2014). GROMACS User Manual version, 5(2), 1–298.

2. Identifying natural compounds as multi-target-directed ligands against Alzheimer’s disease: an in silico approach

3. Screening of promising molecules against MurG as drug target in multi-drug-resistant-Acinetobacter baumannii - insights from comparative protein modeling, molecular docking and molecular dynamics simulation

4. Structure based in-silico study on UDP-N-acetylmuramoyl-L-alanyl-D-glutamate-2,6-diaminopimelate ligase (MurE) from Acinetobacter baumannii as a drug target against nosocomial infections

5. Toward the estimation of the absolute quality of individual protein structure models

Cited by 237 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial intelligence for drug repurposing against infectious diseases;Artificial Intelligence Chemistry;2024-12

2. Fragment-based Drug Discovery Strategy and its Application to the Design of SARS-CoV-2 Main Protease Inhibitor;Current Medicinal Chemistry;2024-11

3. Deciphering inhibitory activity of marine algae Ecklonia cava phlorotannins against SARS CoV-2 main protease: A coupled in-silico docking and molecular dynamics simulation study;Gene;2024-10

4. Phytocompounds as versatile drug-leads targeting mProtease in the SARS-CoV-2 virus: insights from a molecular dynamics study;Journal of Biomaterials Science, Polymer Edition;2024-07-30

5. Artemisinin derivatives as potential drug candidates against Mycobacterium tuberculosis : insights from molecular docking, MD simulations, PCA, MM/GBSA and ADMET analysis;Molecular Simulation;2024-05-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3